drugset / Trial / NCT04805606

A Clinical Traial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843

NCT04805606 ↗

Phase 1 Completed 40 enrolled Chong Kun Dang Pharmaceutical
RandomizedParallel-groupOpen-labelTreatment

Summary

A Clinical Traial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843

Timeline

Start
2021-04-30
Primary completion
2021-12-24
Completion
2021-12-24

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-843 A Unknown 27 mg —
Subject CKD-843 A Unknown 45 mg —
Subject CKD-843 A Unknown 56 mg —
Subject CKD-843 B Unknown 45 mg —
Comparator CKD-843-R Unknown — Oral

Indications